ICDcodes.org
FY2027

E70.321Tyrosinase positive oculocutaneous albinism

BillableCC

Is E70.321 billable?

Yes — E70.321 is billable for FY2027. E70.321 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E70.321 may be submitted for encounters from October 1, 2026 through September 30, 2027.

E70.321 at a glance

CodeE70.321
DescriptionTyrosinase positive oculocutaneous albinism
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does E70.321 group to?

E70.321 sits in MDC 10 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 642Inborn and Other Disorders of Metabolismmedical

As a secondary diagnosis, E70.321 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.

How is E70.321 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E70.321. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Albinism, albinoII
  • Albinism, albinooculocutaneoustyrosinasepositive

Inclusion terms

Alternative wording in documentation that is classified to E70.321.

  • Albinism II
  • Oculocutaneous albinism ty-pos

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E70.321 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E70-E88

The conditions below can never be reported together with E70.321 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)

Excludes1 — never code together — inherited from E70.32

The conditions below can never be reported together with E70.321 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

Excludes2 — not included here — inherited from E70-E88

The conditions below are not part of E70.321, but a patient may have both at the same time. When documentation supports it, E70.321 and the excluded code may both be reported.

  • Ehlers-Danlos syndromes (Q79.6-)

How long has E70.321 existed?

E70.321 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

Which conditions are coded to E70.321?

What other codes are in the E70.32 family? (3)